Thomas Klockgether

The Clinical Ataxia Research Group is studying the clinical and imaging features of degenerative ataxias with a particular focus on the polyglutamine spinocerebellar ataxias (SCAs). Specific goals are to characterize the premanifest disease stage by studying healthy mutations carriers before the onset of ataxia and to develop biomarkers that are useful as sensitive outcome markers in interventional trials. We are currently performing clinical trials in different ataxia disorders that have the goal to find compounds that relieve symptoms. In addition, we preparing trials with disease modifying interventions.

Prof. Dr. Thomas Klockgether
Department of Neurology, University of Bonn
German Center for Neurodegenerative Diseases (DZNE)
Sigmund-Freud-Str. 25
D-53105 Bonn

Phone:  0228 287 15736
Web: here, here

Seine Forschungsinteressen konzentrieren sich auf die Charakterisierung des klinischen Verlaufs und der molekularen Mechanismen neurodegenerativer Krankheiten, insbesondere von Krankheiten, wie Parkinson-Krankheit und Ataxien, die mit Bewegungsstörungen einhergehen.

Go Back